Statistics

Total Visits

Views
Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naive Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial85

Select a period of time:

Number of views in the range

Views
Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naive Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial25

Views

Views
June 20250
July 202513
August 20250
September 20257
October 20251
November 20252
December 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Brazil5
South Africa3
United Kingdom3
Canada1
Ecuador1
 

Top cities views

Views
Dallas6
Cape Town1
Chandler1
Columbus1
Curitiba1
Duque de Caxias1
Johannesburg1
Malacacheta1
Orlando1
Phoenix1